COVID INFORMATION

Pfizer Covid-19 Vaccines Have Arrived!

Vaccine Clinic for Residents and Staff


Next Date To Be Announced.


Informed Consent Required!

(See **Pfizer Fact Sheet Below)


Daily  Covid Updates Available at (718) 989-3043
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

RESIDENT  VISITATION

 

UPDATE


(Updated 05/03/2021)
VISITATION HAS  RESUMED

RESIDENT VISITATION GUIDELINES 

(upon resumption of visitation - schedule subject to change)
For Eger Harbor House Visitation Guidelines, please visit the Medicaid Assisted Living Page (tab  above)
(Visitor Testing Information follows Resident Visitation Guidelines below)

Effective Thursday, May 6, 2021, INDOOR ON UNIT visitation
hours are: 
 10am to Noon and 2:30pm to 7:00pm Every Day; scheduling is not required.

 

Visitation is permitted both indoors and outdoors (weather permitting as defined by the facility).

  • The current schedule by nursing unit will be maintained for the two outdoor patios as an addition to the above indoor visitation hours:

                                       10:30am - 11:10am,11:30 – 12:10pm, 2:00pm – 2:40pm,
                                                 3:00pm – 3:40pm and 4:00pm – 440pm

 

  • Rear Yard Patio = up to 12 long term care residents at one time.
    Schedule online or by calling call 718-989-3074
    Mon – Unit 8, Tues – Unit 7, Wed – Unit 6, Thurs – Unit 4, Fri – Unit 5

 

  • Piano Lounge Patio = up to 7 short-term care residents at one-time.
    Schedule by calling 718-989-3089

 

 

Maintaining the nursing unit schedule for outdoor visitation supports the facility’s objective to prevent an excess of persons outdoors which would violate social distancing requirements.  Scheduling is not required for indoor visitation.

On weekends, outdoor visitation during the hours noted at the top of the page shall be monitored by Security to ensure social distancing requirements are maintained.

Visitation is limited to two (2) visitors per resident.

  • Anyone under the age of 16 must be accompanied by an adult.

 

Upon entering the main lobby, each visitor will complete a health screening for signs and symptoms of COVID-19, asked about having had close contact with someone with the COVID-19 infection during the prior 14 days (regardless of vaccination status) and will have their temperatures taken.

  • A face mask which covers the nose and mouth, to be worn at all times, shall be provided should the visitor not have one.

  • Visitors shall disinfect their hands by using the hand sanitizer at the security desk.
     

The Core Principles of Infection Prevention & Control shall be maintained throughout the visit inclusive of:  wearing a mask which covers the nose and mouth, practice proper and frequent hand hygiene and maintain social distancing from staff and other residents.

 

An Eger employee shall transport residents from the nursing unit to the patio and back to the nursing unit.

  • The facility  is responsible for limiting visitor movement within the facility.


Visiting in a room shared by two residents shall be limited to one resident at a time.
 

Visitor Testing
For the protection of the residents, employees, yourself and family, the facility firmly encourages visitor testing which will continue to be provided as is presently scheduled:

Monday & Wednesday
8:45am to 10:00am and 12:30pm to 1:30pm

 

Outtakes Café - Open Daily until 2pm

Maintain Social Distancing while inside making a purchase.
 

To minimize resident exposure, visitors shall proceed alone to Outtakes to make their purchases.

At this time, occupancy in Outtakes is for employees only.
 

The Café will be closely monitored by an Eger employee.

 

Indoor visitation will be suspended should there be a new case of COVID-19 identified among the employees or residents until one round of “outbreak” testing where all residents and employees are tested without an additional positive case.

  • Should there be no other positive cases, all nursing units shall be opened for visitation except the one unit affected by the positive case; this unit can be re-opened after two rounds of testing (14 days).

  • Should there be another positive result affecting a 2nd nursing unit, visitation throughout the facility shall be suspended until outbreak testing reveals no new positive cases for 14 days.
     

Indoor visitation shall also be suspended during times when there is a high risk of COVID-19 transmission including the following scenarios for:

  • Unvaccinated residents if the nursing homes’ COVID-19 county positivity rate is greater than 10% AND less than 70% of residents in the facility are fully vaccinated;

  • Residents  with confirmed COVID-19 infection, whether vaccinated or unvaccinated  until they have met the criteria to discontinue Transmission-Based Precautions; or

  • Residents in quarantine, whether vaccinated or unvaccinated, until they have met criteria for release from quarantine.

 

Visitors must refrain from visiting if not feeling well; likewise, if a visitor becomes ill after making a visit or tests positive  for COVID, please call Nursing Administration at 718-989-3037.


Any visitor who fails to adhere to the visitation protocols shall be asked to leave the facility.

---------------------------------------------------------------------------------------------------------------

Visitor Testing

Commencing Monday, March 22, 2021
Visitor testing via an Abbott BinaxNow point of care antigen test
shall be provided on Mondays and Wednesdays
from 8:45am to 10:00am and 12:30pm to 1:30pm.
(unless otherwise noted above)

 

Prior to the test, required information will be collected for reporting the test results to the State and Federal Government.
 

The COVID testing process will be performed by two Eger employees while the person(s) being tested remain in the car.  Vehicles shall line up along the curb beginning just prior to the blue canopy at the main entrance.
 

Once the swabbing of each nostril is complete, the vehicle shall drive away allowing for testing of the occupants in the next car.  Test results are available 15 minutes after the test.  An Eger employee shall “only” call those who have a “positive” test result.
 

Visitation will be suspended for at least 14 days for anyone receiving a positive test result.  After 14 days, a negative test result is required to visit the facility. Presenting a negative test result performed prior to 14 days after the positive result will not negate the 14 day no visitation requirement.
 

Test results will remain with Eger security for access upon the visit.  Eger reserves the right not to provide a test result to a person who does not visit.
 

Eger strongly recommends anyone receiving a COVID positive test result to contact their primary physician.

(Daily Updates Available at (718) 989-3043)

​- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

**THE PFIZER-BIONTECH COVID-19 VACCINE
FACT SHEET FOR RECIPIENTS AND CAREGIVERS

EMERGENCY USE AUTHORIZATION (EUA) OF

THE PFIZER-BIONTECH COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19)

IN INDIVIDUALS 16 YEARS OF AGE AND OLDER
(Revised: December 2020)

 

You are being offered the Pfizer-BioNTech COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to help you understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine, which you may receive because there is currently a pandemic of COVID-19.

 

The Pfizer-BioNTech COVID-19 Vaccine is a vaccine and may prevent you from getting COVID-19. There is no U.S. Food and Drug Administration (FDA) approved vaccine to prevent COVID-19.

 

Read this Fact Sheet for information about the Pfizer-BioNTech COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Pfizer-BioNTech COVID-19 Vaccine.

 

The Pfizer-BioNTech COVID-19 Vaccine is administered as a 2-dose series, 3 weeks apart, into the muscle.

 

The Pfizer-BioNTech COVID-19 Vaccine may not protect everyone. This Fact Sheet may have been updated. For the most recent Fact Sheet, please see www.cvdvaccine.com.

 

WHAT YOU NEED TO KNOW BEFORE YOU GET THIS VACCINE?

 

WHAT IS COVID-19?

COVID-19 disease is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.

 

WHAT IS THE PFIZER-BIONTECH COVID-19 VACCINE?

The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19.

The FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to prevent COVID-19 in individuals 16 years of age and older under an Emergency Use Authorization (EUA).

 

For more information on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet.

 

WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE YOU GET THE PFIZER-BIONTECH COVID-19 VACCINE?

Tell the vaccination provider about all of your medical conditions, including if you:

• have any allergies

• have a fever

• have a bleeding disorder or are on a blood thinner

• are immunocompromised or are on a medicine that affects your immune system

• are pregnant or plan to become pregnant

• are breastfeeding

• have received another COVID-19 vaccine

 

WHO SHOULD GET THE PFIZER-BIONTECH COVID-19 VACCINE?

FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine in individuals 16 years of age and older.

 

WHO SHOULD NOT GET THE PFIZER-BIONTECH COVID-19 VACCINE?

You should not get the Pfizer-BioNTech COVID-19 Vaccine if you:

• had a severe allergic reaction after a previous dose of this vaccine

• had a severe allergic reaction to any ingredient of this vaccine

 

WHAT ARE THE INGREDIENTS IN THE PFIZER-BIONTECH COVID-19 VACCINE?

The Pfizer BioNTech COVID-19 Vaccine includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.

 

HOW IS THE PFIZER-BIONTECH COVID-19 VACCINE GIVEN?

The Pfizer-BioNTech COVID-19 Vaccine will be given to you as an injection into the muscle.

 

The Pfizer-BioNTech COVID-19 Vaccine vaccination series is 2 doses given 3 weeks apart.

 

If you receive one dose of the Pfizer-BioNTech COVID-19 Vaccine, you should receive a second dose of this same vaccine 3 weeks later to complete the vaccination series.

HAS THE PFIZER-BIONTECH COVID-19 VACCINE BEEN USED BEFORE?

The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine. In clinical trials, approximately 20,000 individuals 16 years of age and older have received at least 1 dose of the Pfizer-BioNTech COVID-19 Vaccine.

 

WHAT ARE THE BENEFITS OF THE PFIZER-BIONTECH COVID-19 VACCINE?
In an ongoing clinical trial, the Pfizer-BioNTech COVID-19 Vaccine has been shown to prevent COVID-19 following 2 doses given 3 weeks apart. The duration of protection against COVID-19 is currently unknown.

 

WHAT ARE THE RISKS OF THE PFIZER-BIONTECH COVID-19 VACCINE?

Side effects that have been reported with the Pfizer-BioNTech COVID-19 Vaccine include:

• injection site pain

• tiredness

• headache

• muscle pain

• chills

• joint pain

• fever

• injection site swelling

• injection site redness

• nausea

• feeling unwell

• swollen lymph nodes (lymphadenopathy)

 

There is a remote chance that the Pfizer-BioNTech COVID-19 Vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Pfizer-BioNTech COVID-19 Vaccine. Signs of a severe allergic reaction can include:

• Difficulty breathing

• Swelling of your face and throat

• A fast heartbeat

• A bad rash all over your body

• Dizziness and weakness

 

These may not be all the possible side effects of the Pfizer-BioNTech COVID-19 Vaccine. Serious and unexpected side effects may occur. Pfizer-BioNTech COVID-19 Vaccine is still being studied in clinical trials.

 

WHAT SHOULD I DO ABOUT SIDE EFFECTS?

If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital.

 

Call the vaccination provider or your healthcare provider if you have any side effects that bother you or do not go away.

Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to https://vaers.hhs.gov/reportevent.html. Please include “Pfizer-BioNTech COVID-19 Vaccine EUA” in the first line of box #18 of the report form.

 

In addition, you can report side effects to Pfizer Inc. at the contact information provided below.

Website  www.pfizersafetyreporting.com 
Fax number   1-866-635-8337

Telephone number  1-800-438-1985

 

WHAT IF I DECIDE NOT TO GET THE PFIZER-BIONTECH COVID-19 VACCINE?

It is your choice to receive or not receive the Pfizer-BioNTech COVID-19 Vaccine. Should you decide not to receive it, it will not change your standard medical care.

 

ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES PFIZER-BIONTECH COVID-19 VACCINE?

Currently, there is no approved alternative vaccine available for prevention of COVID-19. FDA may allow the emergency use of other vaccines to prevent COVID-19.

 

CAN I RECEIVE THE PFIZER-BIONTECH COVID-19 VACCINE WITH OTHER VACCINES?

There is no information on the use of the Pfizer-BioNTech COVID-19 Vaccine with other vaccines.

 

WHAT IF I AM PREGNANT OR BREASTFEEDING?

If you are pregnant or breastfeeding, discuss your options with your healthcare provider.

 

WILL THE PFIZER-BIONTECH COVID-19 VACCINE GIVE ME COVID-19?

No. The Pfizer-BioNTech COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.

 

KEEP YOUR VACCINATION CARD

When you get your first dose, you will get a vaccination card to show you when to return for your second dose of Pfizer-BioNTech COVID-19 Vaccine. Remember to bring your card when you return.

ADDITIONAL INFORMATION

If you have questions, visit the website or call the telephone number provided below.
To access the most recent Fact Sheets, please visit the  Global website:  www.cvdvaccine.com  or Call :Telephone:  1-877-829-2619 (1-877-VAX-CO19)

 

HOW CAN I LEARN MORE?

• Ask the vaccination provider.

• Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. • Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization.

• Contact your local or state public health department.

 

WHERE WILL MY VACCINATION INFORMATION BE RECORDED?

The vaccination provider may include your vaccination information in your state/local jurisdiction’s Immunization Information System (IIS) or other designated system. This will ensure that you receive the same vaccine when you return for the second dose. For more information about IISs visit: https://www.cdc.gov/vaccines/programs/iis/about.html.

 

WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM? The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp/ or call 1-855-266-2427.

 

WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)?

The United States FDA has made the Pfizer-BioNTech COVID-19 Vaccine available under an emergency access mechanism called an EUA. The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic.

 

The Pfizer-BioNTech COVID-19 Vaccine has not undergone the same type of review as an FDA-approved or cleared product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, available alternatives. In addition, the FDA decision is based on the totality of scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used in the treatment of patients during the COVID-19 pandemic.

 

The EUA for the Pfizer-BioNTech COVID-19 Vaccine is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of these products, unless terminated or revoked (after which the products may no longer be used).

 

Manufactured by Pfizer Inc., New York, NY 10017

Manufactured for

BioNTech Manufacturing GmbH

An der Goldgrube 12

55131 Mainz, Germany

 

LAB-1451-0.7

Revised: December 2020